Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.35% |
| 2 | Energy | 10.93% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.18% |
| 5 | Technology | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESGR
2926
DELISTED
Enstar Group
ESGR
| $285K | ﹤0.01% |
+1,899
| New | +$294K |
|
2927
MasTec
MTZ
$24.7B
| $285K | ﹤0.01% |
18,000
-833,427
| -98% | -$14.5M |
|
|
CNW
2928
CALL
DELISTED
CON-WAY INC.
CNW
| $285K | ﹤0.01% |
+6,000
| New | +$235K |
|
2929
Cardiff Oncology
CRDF
$63.6M
| $284K | ﹤0.01% |
+693
| New | +$363K |
|
2930
Paylocity
PCTY
$7.43B
| $284K | ﹤0.01% |
+9,465
| New | +$322K |
|
2931
Twin Disc
TWIN
$333M
| $284K | ﹤0.01% |
+22,861
| New | +$339K |
|
|
FFIC
2932
DELISTED
Flushing Financial
FFIC
| $283K | ﹤0.01% |
+14,124
| New | +$289K |
|
2933
Global Indemnity Group
GBLI
$405M
| $283K | ﹤0.01% |
+10,799
| New | +$296K |
|
2934
VanEck Pharmaceutical ETF
PPH
$987M
| $283K | ﹤0.01% |
4,500
-7,267
| -62% | -$511K |
|
|
GNCMA
2935
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $282K | ﹤0.01% |
16,338
-48,217
| -75% | -$847K |
|
2936
Lindsay Corp
LNN
$1.17B
| $281K | ﹤0.01% |
4,144
-10,318
| -71% | -$818K |
|
2937
Natera
NTRA
$36.1B
| $281K | ﹤0.01% |
+25,936
| New | +$440K |
|
2938
Towne Bank
TOWN
$3.53B
| $281K | ﹤0.01% |
14,901
-19,762
| -57% | -$354K |
|
2939
National Presto Industries
NPK
$884M
| $280K | ﹤0.01% |
3,326
-2,933
| -47% | -$238K |
|
2940
Camden National
CAC
$979M
| $279K | ﹤0.01% |
+10,356
| New | +$276K |
|
2941
WD-40
WDFC
$3.08B
| $279K | ﹤0.01% |
+3,136
| New | +$273K |
|
|
VSLR
2942
DELISTED
VIVINT SOLAR, INC.
VSLR
| $279K | ﹤0.01% |
+26,612
| New | +$343K |
|
|
CEMP
2943
CALL
DELISTED
Cempra, Inc.
CEMP
| $278K | ﹤0.01% |
+10,000
| New | +$371K |
|
|
AHT
2944
Ashford Hospitality Trust
AHT
$20.9M
| $277K | ﹤0.01% |
46
-215
| -82% | -$1.71M |
|
|
MN
2945
DELISTED
MANNING & NAPIER, INC.
MN
| $277K | ﹤0.01% |
37,670
-159,749
| -81% | -$1.52M |
|
|
GBSN
2946
DELISTED
GREAT BASIN SCIENTIFIC INC COM PAR $.0001 NEW
GBSN
| $277K | ﹤0.01% |
+16
| New | +$4.28M |
|
2947
Gaia
GAIA
$47.6M
| $276K | ﹤0.01% |
44,946
+18,016
| +67% | +$115K |
|
2948
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
| $276K | ﹤0.01% |
+6,228
| New | +$295K |
|
|
OMN
2949
DELISTED
OMNOVA Solutions Inc.
OMN
| $276K | ﹤0.01% |
49,827
+26,194
| +111% | +$168K |
|
|
CELGZ
2950
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $275K | ﹤0.01% |
170,590
-84,660
| -33% | -$163K |
|
Similar funds
Millennium Management's Q3 2015 Portfolio in Review
As of Q3 2015, Millennium Management held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Millennium Management deployed $5.12B of net new capital in Q3 2015, opening 840 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Millennium Management's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Millennium Management added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Millennium Management's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Millennium Management fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Millennium Management's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Millennium Management opened 840 new positions and closed 681 in Q3 2015.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.